PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAC8. A total of 20 filers reported holding PDL BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $3,118,000 | +3.8% | 2,371,000 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $3,005,000 | -20.6% | 2,371,000 | 0.0% | 0.01% | -25.0% |
| Q2 2014 | $3,785,000 | -40.4% | 2,371,000 | -49.0% | 0.01% | -42.9% |
| Q1 2014 | $6,349,000 | +0.9% | 4,651,000 | 0.0% | 0.01% | -6.7% |
| Q4 2013 | $6,293,000 | -12.9% | 4,651,000 | -17.1% | 0.02% | -21.1% |
| Q3 2013 | $7,226,000 | +4.4% | 5,610,000 | +99900.0% | 0.02% | -5.0% |
| Q2 2013 | $6,921,000 | – | 5,610 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|